Prevalence and Determinants of Multidrug-Resistant Tuberculosis in Makkah, Saudi Arabia

References

• WHO. Global Tuberculosis Report 2019. Geneva: World Health Organization; 2019.
   Google Scholar
• Kumar K, Kon O. Diagnosis and treatment of tuberculosis: latest developments and future priorities. Ann Res Hosp. 2017;10.
   Google Scholar
• Al-Hajoj S, Varghese B, Shoukri MM, et al. Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey. Antimicrob Agents Chemother. 2013;57(5):2161–2166.23459478
   PubMed Web of Science ®Google Scholar
• Control C. Prevention. Primary multidrug-resistant tuberculosis–Ivanovo Oblast, Russia, 1999. MMWR Morb Mortal Wkly Rep. 1999;48(30):661.10488782
   PubMedGoogle Scholar
• Tuberculosis I, Disease L. Field guide for the management of drug-resistant tuberculosis. Int Union Against Tuberculosis Lung Dis. 2018;254.
   Google Scholar
• Abu-Amero KK. Review of the current status of drug-resistant tuberculosis in Saudi Arabia. Ann Saudi Med. 2002;22(3–4):236–238.17159406
   PubMed Web of Science ®Google Scholar
• Al Ammari M, Al Turaiki A, Al Essa M, Kashkary AM, Eltigani SA, Ahmed AE. Drug resistant tuberculosis in Saudi Arabia: an analysis of surveillance data 2014–2015. Antimicrob Resist Infect Control. 2018;7:12.29387346
   PubMed Web of Science ®Google Scholar
• Ali Chaudhry L, Rambhala N, Al-Shammri AS, Al-Tawfiq JA. Patterns of antituberculous drug resistance in Eastern Saudi Arabia: a 7-year surveillance study from 1/2003 to 6/2010. J Epidemiol Glob Health. 2012;2(1):57–60.23856399
   PubMedGoogle Scholar
• Elhassan MM, Hemeg HA, Elmekki MA, Turkistani KA, Abdul-Aziz AA. Burden of Multidrug Resistant Mycobacterium tuberculosis Among New Cases in Al-Madinah Al-Monawarah, Saudi Arabia. Infect Disord Drug Targets. 2017;17(1):14–23.27848902
   PubMedGoogle Scholar
• Asaad AM, Alqahtani JM. Primary anti-tuberculous drugs resistance of pulmonary tuberculosis in Southwestern Saudi Arabia. J Infect Public Health. 2012;5(4):281–285. doi:10.1016/j.jiph.2012.03.00523021650
   PubMedGoogle Scholar
• Areeshi MY, Bisht SC, Mandal RK, Haque S. Prevalence of drug resistance in clinical isolates of tuberculosis from GCC: a literature review from January 2002 to March 2013. J Infect Dev Countries. 2014;8(09):1137–1147.
   Web of Science ®Google Scholar
• Department of TB Control. The 2012 Report of Fighting Tuberculosis in Turkey. Ankara, Turkey: Ministry of Health; 2013.
   Google Scholar
• Ahmed MM, Velayati AA, Mohammed SH. Epidemiology of multidrug-resistant, extensively drug resistant, and totally drug resistant tuberculosis in Middle East countries. Int j Mycobacteriology. 2016;5(3):249–256.
   Google Scholar
• World Health Organization. Global Tuberculosis Report 2015 2015. Geneva, Switzerland: WHO; 2015.
   Google Scholar
• Alzeer A, Mashlah A, Fakim N, et al. Tuberculosis is the commonest cause of pneumonia requiring hospitalization during Hajj (pilgrimage to Makkah). J Infect. 1998;36(3):303–306.9661941
   PubMed Web of Science ®Google Scholar
• Ruddy M, Balabanova Y, Graham C, et al. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax. 2005;60(2):130–135.15681501
   PubMed Web of Science ®Google Scholar
• Mulu W, Mekkonnen D, Yimer M, Admassu A, Abera B. Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State. Afr Health Sci. 2015;15(2):368–377.26124781
   PubMed Web of Science ®Google Scholar
• Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax. 2006;61(2):158–163.16254056
   PubMed Web of Science ®Google Scholar
• Demile B, Zenebu A, Shewaye H, Xia S, Guadie A. Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia. BMC Infect Dis. 2018;18(1):249.29855354
   PubMed Web of Science ®Google Scholar
• Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie S, Kumera G. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia. BMC Infect Dis. 2015;15(1):461.26503269
   PubMed Web of Science ®Google Scholar
• Metanat M, Sharifi-Mood B, Shahreki S, Dawoudi S. Prevalence of multidrug-resistant and extensively drug-resistant tuberculosis in patients with pulmonary tuberculosis in zahedan, southeastern iran. Iran Red Crescent Med J. 2012;14(1):53.22737557
   PubMed Web of Science ®Google Scholar
• Mehari K, Asmelash T, Hailekiros H, et al. Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia. Canadian J Infect Dis Med Microbiol. 2019;2019.
   Web of Science ®Google Scholar
• Tegegne BS, Habtewold TD, Mengesha MM, Burgerhof JGM. Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis. Syst Rev. 2017;6(1):6.28088237
   PubMed Web of Science ®Google Scholar
• Zhao J-N, Zhang X-X, He X-C, et al. Multidrug-resistant tuberculosis in patients with chronic obstructive pulmonary disease in China. PLoS One. 2015;10:8.
   Web of Science ®Google Scholar
• Gomes M, Correia A, Mendonça D, Duarte R. Risk factors for drug-resistant tuberculosis. J Tuberculosis Res. 2014;2014.
   Google Scholar
• Stosic M, Vukovic D, Babic D, et al. Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: a case-control study. PLoS One. 2018;18(1):1114.
   Google Scholar